Skip Navigation

Bioscience Horizons 2008 1(1):9-18; doi:10.1093/biohorizons/hzn002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brierley-Hobson, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Brierley-Hobson, S.
Related Collections
Right arrow Biochemistry
Right arrow Biotechnology
Right arrow Cell Biology
Right arrow Molecular Biology
Right arrow Nutrition
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008

Binding of (-)-epigallocatechin-3-gallate to the Hsp70 ATPase domain may promote apoptosis in colorectal cancer

Sue Brierley-Hobson*

University of Chester, Chester, UK

* Corresponding author: Goleufryn, Pendre Road, Penrhynside, Llandudno, Conwy LL30 3DG, UK. Tel: + 44 01492 548293. Email: sue{at}pudins.fsworld.co.uk

Supervisor: Professor Sarah Andrew, University of Chester, Chester, UK.


  Abstract

Colorectal cancer (CRC) patients frequently have a poor prognosis because of metastases and drug resistance. Heat-shock protein 70 (Hsp70) over-expression in cancer may exacerbate these factors by inhibiting apoptosis, thus providing a potential therapeutic target. The green tea flavonoid (-)-epigallocatechin-3-gallate (EGCG) induces apoptosis in numerous cancer cell lines by unclear mechanisms. This study proposed and investigated a novel mechanism by which EGCG might inhibit the anti-apoptotic activity of Hsp70, namely, by competing with adenosine triphosphate (ATP) for binding to the Hsp70 ATPase domain. It also examined the impact of EGCG on the CRC cell line HT-29, which is known to over-express Hsp70.

HT-29 cells were treated with 10–300 µM EGCG for 8, 24 and/or 48 h, then analysed using an MTS proliferation-assay or flow cytometry with Annexin V-FITC and propidium iodide. The competitive binding of EGCG to the Hsp70 ATPase domain was assessed using ATP-agarose, a dot blot and chemiluminescence techniques.

EGCG significantly (P < 0.001) and dose-dependently inhibited HT-29 cell viability. Viability was inhibited by 50% (IC50) at 89 µM and 74 µM after 24- and 48-h treatments, respectively, also suggesting a time-dependent effect. Apoptosis was induced both dose- and time-dependently, commencing at 50 µM after 8- and 24-h treatments. Further, apoptosis correlated significantly (P < 0.01) with reduced viability as measured by MTS at 24 h, indicating 98% causality. The dot blot suggested 200 µM EGCG competed with ATP for binding to Hsp70, presumably by binding its ATPase domain, theoretically implying this flavonoid could inhibit the anti-apoptotic effect of Hsp70.

Key words: colorectal cancer, (-)-epigallocatechin-3-gallate, Hsp70, apoptosis

Submitted on 24 September 2007; accepted on 17 December 2007


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.